$1.89
-0.07-3.57%
Pre-Market: Apr 4, 7:54 PM EDT
Comments
Loading...
Traws Pharma Earnings Estimates, EPS & Revenue | NASDAQ:TRAW | Benzinga
Traws Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS Estimate
$-8.040
Quarterly Revenue Estimate
$60.00K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$226.00K
Analyze the earnings history of Traws Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TRAW | Traws Pharma | -$6.00 | -$8.04 | — | — | $56.00K | $60.00K | — | — | 05/14/2025 | Get Alert |
| TRAW | Traws Pharma | -$5.00 | -$9.55 | -$9.72 | -1.78% | $56.00K | $60.00K | $56.00K | -6.67% | 03/31/2025 | Get Alert |
| TRAW | Traws Pharma | -$5.64 | — | -$8.81 | — | $57.00K | — | $57.00K | — | 11/14/2024 | Get Alert |
| TRAW | Traws Pharma | -$5.00 | — | -$121.75 | — | $60.00K | — | $57.00K | — | 08/15/2024 | Get Alert |
| TRAW | Traws Pharma | -$7.00 | — | -$6.00 | — | $56.00K | — | $56.00K | — | 05/15/2024 | Get Alert |
| TRAW | Traws Pharma | — | — | -$5.00 | — | — | — | $56.00K | — | 04/01/2024 | Get Alert |
Traws Pharma (TRAW) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-31 | $-9.72 | $-9.55 | -1.78 % |
Traws Pharma (TRAW) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-31 | $56.00K | $60.00K | -6.67 % |
FAQ
When is Traws Pharma (NASDAQ:TRAW) reporting earnings?
Traws Pharma (TRAW) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on March 31, 2025 for Q4.
What were the latest earnings per share (EPS) for Traws Pharma (NASDAQ:TRAW)?
The Actual EPS was $-9.72, which missed the estimate of $-9.55.
What were Traws Pharma’s (NASDAQ:TRAW) revenues?
The Actual Revenue was $56K, which missed the estimate of $60K.
Browse earnings estimates, EPS, and revenue on all stocks.